What are the recommended intravenous (IV) dosing regimens, contraindications, and precautions for Deriphylline (theophylline) injection in adults and children with acute bronchospasm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Deriphylline (Theophylline/Aminophylline) Injection Dosing and Guidelines

Critical First Principle: Aminophylline is NOT First-Line Therapy

Aminophylline should only be administered for acute bronchospasm if the patient remains unresponsive after 15-30 minutes of optimal first-line therapy with nebulized beta-agonists and systemic corticosteroids. 1 Inhaled beta-2 selective agonists are far more effective for acute bronchospasm, and theophylline provides no added benefit when adequate beta-agonist therapy is available. 2


IV Loading Dose for Acute Bronchospasm

For Theophylline-Naive Adults

  • Administer 5-6 mg/kg aminophylline IV over 20-30 minutes (approximately 250-500 mg for average adult), diluted in 100-200 mL of IV fluid. 1
  • Alternative simplified dosing: 250 mg IV bolus over 20 minutes for life-threatening bronchospasm. 1
  • Never administer as rapid IV push—the 20-30 minute infusion time is essential to avoid serious toxicity including arrhythmias, hypotension, and seizures. 1

For Theophylline-Naive Children (1-15 years)

  • Administer 5 mg/kg aminophylline IV over 20 minutes, followed by continuous infusion of 1 mg/kg/hour. 1
  • For children ages 1-9 years with normal organ function, use 5.7 mg/kg loading dose over 20 minutes, then 1.0 mg/kg/hour maintenance. 1

For Infants (<1 year)

  • Premature neonates <24 days: 1 mg/kg every 12 hours 2
  • Premature neonates ≥24 days: 1.5 mg/kg every 12 hours 2
  • Full-term infants: Total daily dose (mg) = [(0.2 × age in weeks) + 5.0] × (kg body weight), divided into doses every 6-8 hours 2

Maintenance Infusion Dosing

Standard Adult Dosing

  • 0.5-1 mg/kg/hour continuous infusion after loading dose 1
  • Practical approach: 750 mg/24 hours for small patients, 1500 mg/24 hours for large patients 1

High-Risk Populations (Reduced Clearance)

  • Elderly patients (>65 years): 0.4 mg/kg/hour 1
  • Patients with liver disease: 0.4 mg/kg/hour 1
  • Patients with cardiac disease: 0.4 mg/kg/hour 1

Pediatric Maintenance

  • Children 1-15 years: 1 mg/kg/hour continuous infusion 1

Critical Safety Monitoring

Mandatory Monitoring During Administration

  • Continuous cardiac monitoring throughout the infusion 1
  • Target therapeutic serum concentration: 10-20 mcg/mL (5-10 mcg/mL in neonates) 1, 2
  • Check serum theophylline levels at 12-24 hour intervals during maintenance infusion 1
  • If infusion continues beyond 24 hours, monitor blood concentrations regularly 1

Dose Adjustment Based on Serum Levels

  • <9.9 mcg/mL: Increase dose by 25% if tolerated 2
  • 10-14.9 mcg/mL: Maintain current dose 2
  • 15-19.9 mcg/mL: Consider dose reduction 2
  • ≥20 mcg/mL: Hold dose, reduce when restarting 2

Absolute Contraindications and Precautions

Do NOT Give Aminophylline If:

  • Patient is already on maintenance oral theophylline—68% of such patients already have therapeutic levels, and 9% have toxic levels before receiving additional IV doses 3
  • If patient has received theophylline in previous 24 hours, do NOT give standard loading dose—risk of severe toxicity 2
  • Patient has adequate response to inhaled beta-agonists alone 1

Compatibility Warnings

  • Do NOT mix with epinephrine HCl, isoproterenol HCl, or norepinephrine bitartrate—aminophylline is incompatible with these drugs 1
  • Administer through separate IV line if other medications are being given 1

Clinical Decision Algorithm

Step 1: Confirm Inadequate Response to First-Line Therapy

  • Patient must have received high-flow oxygen, nebulized beta-agonist, and systemic corticosteroids 1
  • Wait 15-30 minutes to assess response 1
  • Consider adding ipratropium 0.5 mg to nebulizer and increasing beta-agonist frequency to every 15-30 minutes before aminophylline 1

Step 2: Verify No Recent Theophylline Use

  • Ask specifically about oral theophylline maintenance therapy—most patients on chronic theophylline already have therapeutic levels 3
  • If any theophylline use in past 24 hours, check serum level before giving loading dose 2

Step 3: Administer Loading Dose with Monitoring

  • Dilute in 100-200 mL IV fluid 1
  • Infuse over 20-30 minutes minimum 1
  • Continuous cardiac monitoring 1

Step 4: Initiate Maintenance Infusion

  • Start appropriate weight-based infusion rate based on patient category 1
  • Check serum level at 12-24 hours 1

Common Pitfalls to Avoid

Pitfall #1: Giving Aminophylline Too Early

The British Thoracic Society emphasizes aminophylline should only be considered after documented failure of optimal bronchodilator therapy—it is not a first-line agent. 1

Pitfall #2: Rapid IV Push Administration

Rapid administration causes life-threatening toxicity—always infuse over 20-30 minutes minimum. 1 This is the most common preventable error.

Pitfall #3: Ignoring Chronic Theophylline Use

Research shows 68% of patients on maintenance theophylline already have therapeutic levels when presenting with acute exacerbation—giving standard loading doses causes toxicity. 3

Pitfall #4: Inadequate Monitoring

Serum levels must be checked at 12-24 hour intervals during acute therapy, as FDA dosing guidelines are unreliable in many patient categories. 4

Pitfall #5: Using in COPD Exacerbations

Evidence for aminophylline effectiveness in acute COPD exacerbations is limited, and it should only be considered if patients are not responding to initial therapy. 5


Dosing Based on Body Weight

  • Calculate dose based on ideal body weight, not actual weight—theophylline distributes poorly into body fat 2
  • This is particularly important in obese patients to avoid overdosing 2

References

Guideline

Aminophylline Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Inadequacy of FDA dosing guidelines for intravenous theophylline.

Drug intelligence & clinical pharmacy, 1984

Guideline

Management of Acute Exacerbation of COPD

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.